Search

Your search keyword '"Caslake, Muriel"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Caslake, Muriel" Remove constraint Author: "Caslake, Muriel" Database OAIster Remove constraint Database: OAIster
40 results on '"Caslake, Muriel"'

Search Results

1. Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use

2. Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use

3. Genetic invalidation of Lp-PLA2 as a therapeutic target:Large-scale study of five functional Lp-PLA2-lowering alleles

4. Genetic invalidation of Lp-PLA2 as a therapeutic target:Large-scale study of five functional Lp-PLA2-lowering alleles

5. Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension

6. Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension

7. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

8. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

9. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease.

10. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

11. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

12. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease.

13. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

14. Does high-density lipoprotein protect vascular function in healthy pregnancy?

15. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

16. Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension

17. Maternal Obesity Is Associated With the Formation of Small Dense LDL and Hypoadiponectinemia in the Third Trimester

18. Genetic associations with valvular calcification and aortic stenosis

19. Genetic associations with valvular calcification and aortic stenosis

20. Maternal obesity is associated with the formation of small dense LDL and hypoadiponectinemia in the third trimester

21. Maternal obesity is associated with the formation of small dense LDL and hypoadiponectinemia in the third trimester

22. C-reactive protein, fibrinogen, and cardiovascular disease prediction

23. Lipid-Related Markers and Cardiovascular Disease Prediction

24. C-reactive protein, fibrinogen, and cardiovascular disease prediction

25. C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction

26. Lipid-related markers and cardiovascular disease prediction

27. C-reactive protein, fibrinogen, and cardiovascular disease prediction

28. C-reactive protein, fibrinogen, and cardiovascular disease prediction

29. Lipid-related markers and cardiovascular disease prediction

30. C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction

40. Studies on the Structural and Metabolic Heterogeneity in Low Density Lipoprotein

Catalog

Books, media, physical & digital resources